enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / Common Stock, $0.00001 par value per share
Symbol
NVNO on Nasdaq
Shares outstanding
20,250,000
Price per share
$0.32
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
5,965,202
Total reported value
$5,403,122
% of total 13F portfolios
0%
Share change
+885,267
Value change
-$2,803,262
Number of holders
36
Price from insider filings
$0.32
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SATTERFIELD THOMAS A JR 9% $1,348,650 1,822,500 Thomas A. Satterfield, Jr. 14 Nov 2025
KINGDON CAPITAL MANAGEMENT, L.L.C. 7.1% $5,804,044 1,359,261 Kingdon Capital Management, L.L.C. 02 Sep 2025
Nantahala Capital Management, LLC 3.5% -51% $624,180 -$540,807 688,940 -46% Nantahala Capital Management, LLC 30 Sep 2025

As of 30 Sep 2025, 36 institutional investors reported holding 5,965,202 shares of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO). This represents 29% of the company’s total 20,250,000 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) together control 29% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PERCEPTIVE ADVISORS LLC 8.7% 1,759,035 +37% 0.05% $1,593,686
KINGDON CAPITAL MANAGEMENT, L.L.C. 6.7% 1,359,261 +58% 0.19% $1,231,626
VANGUARD GROUP INC 4.3% 861,191 +23% 0% $780,239
CM Management, LLC 3% 600,000 0.45% $543,660
Westside Investment Management, Inc. 1.1% 212,800 -24% 0.03% $192,816
GEODE CAPITAL MANAGEMENT, LLC 0.99% 201,244 +0.87% 0% $182,368
JPMORGAN CHASE & CO 0.9% 182,322 +0.01% 0% $165,202
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.76% 154,471 0% $139,966
JANE STREET GROUP, LLC 0.35% 71,771 +459% 0% $65,032
BlackRock, Inc. 0.3% 59,857 +4.3% 0% $54,236
HRT FINANCIAL LP 0.27% 55,135 0% $49,000
CITADEL ADVISORS LLC 0.27% 54,811 +88% 0% $49,664
XTX Topco Ltd 0.21% 42,042 +139% 0% $38,094
STATE STREET CORP 0.2% 40,800 0% 0% $36,969
MARSHALL WACE, LLP 0.2% 39,883 0% $36,294
Creative Planning 0.19% 38,295 +184% 0% $34,699
NORTHERN TRUST CORP 0.19% 38,081 -37% 0% $34,505
Fermata Advisors, LLC 0.18% 37,449 -6.5% 0.01% $33,933
RENAISSANCE TECHNOLOGIES LLC 0.14% 29,200 +116% 0% $26,458
AQR CAPITAL MANAGEMENT LLC 0.11% 22,832 0% $20,688
WOLVERINE TRADING, LLC 0.09% 18,339 +63% 0% $17,204
TWO SIGMA SECURITIES, LLC 0.07% 14,111 0% $12,786
Tamar Securities, LLC 0.07% 13,990 0% 0% $12,677
SIMPLEX TRADING, LLC 0.07% 13,751 0% $12,000
GSA CAPITAL PARTNERS LLP 0.07% 13,420 0% $12,000

Institutional Holders of enVVeno Medical Corp - Common Stock, $0.00001 par value per share (NVNO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 32,717 $10,496 -$1,518 $0.32 1
2025 Q3 5,965,202 $5,403,122 -$2,803,262 $0.91 36
2025 Q2 5,079,935 $20,269,051 +$6,075,451 $3.99 36
2025 Q1 3,640,381 $9,573,837 -$1,748,914 $2.63 30
2024 Q4 4,263,270 $12,878,793 -$3,370,239 $3.02 35
2024 Q3 5,209,889 $17,503,055 +$5,731,334 $3.36 35
2024 Q2 3,289,256 $17,267,988 -$1,696,568 $5.25 25
2024 Q1 3,643,857 $19,822,808 -$2,947,912 $5.44 31
2023 Q4 4,248,631 $21,838,067 +$10,299,470 $5.14 29
2023 Q3 1,931,716 $10,411,381 +$240,978 $5.39 23
2023 Q2 1,917,021 $5,904,248 +$322,837 $3.08 22
2023 Q1 1,812,147 $8,498,422 +$709,547 $4.68 18
2022 Q4 1,659,323 $8,461,848 -$813,295 $5.10 22
2022 Q3 2,185,470 $13,727,584 +$305,043 $6.28 20
2022 Q2 2,145,805 $8,111,390 +$183,530 $3.78 20
2022 Q1 2,038,463 $12,985,879 -$292,702 $6.37 20
2021 Q4 2,080,875 $13,711,600 +$13,093,583 $6.59 23
2021 Q3 12,207 $127,000 +$127,000 $10.40 1